Dexloxiglumide is an orally active and selective cholecystokinin type A (CCKA) receptor antagonist and the pharmacologically active enantiomer of Loxiglumide, effectively inhibiting smooth muscle contractions induced by cholecystokinin-octapeptide (CCK-8), while displaying moderate, polarized, concentration-dependent, and pH-dependent Caco-2 permeability and increasing uptake of the MRP1 substrate fluorescein. Dexloxiglumide supports the mechanistic studies of gastrointestinal disorders and tumor-related smooth muscle and transporter biology.
Molecular Weight:
461.38
CAS Number:
[119817-90-2]
Formula:
C21H30Cl2N2O5
Target:
Cholecystokinin Receptor
T15105
T15105
* VAT and and shipping costs not included. Errors and price changes excepted
